Angelica de Lima das Chagas

Ms. Angelica de Lima das Chagas

Universidade Federal de Goiás - UFG - Brasil
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MRMaycon Carvalho Ribeiro
Maycon Carvalho Ribeiro
VCViviane Lopes Rocha Correa
Viviane Lopes Rocha Correa
FSFrancenya Kelley Lopes da Silva
Francenya Kelley Lopes da Silva
ACAriadine Amorim Casas
Ariadine Amorim Casas
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
LMLiliana Borges de Menezes
Liliana Borges de Menezes

10 February 2022 in Materials
Verified
Journal Article
Open access
PDF file
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
LOLeiny Paula de Oliveira
Leiny Paula de Oliveira
MCMauricio Vicente Cruz
Mauricio Vicente Cruz
RMRenato Miranda de Melo
Renato Miranda de Melo
MMMarina Pacheco Miguel
Marina Pacheco Miguel
LMLiliana Borges de Menezes
Liliana Borges de Menezes
Polymeric membranes are a viable and sustainable option for the biotechnology industry from an economic and environmental point of view. In this study, we evaluated tissue response and tolerance to the implantation of a polymeric membrane prepared with cashew gum polysaccharide (CGP) associated with polyvinyl alcohol (PVA). The objective was to characterize the biocompatibility of the CGP/PVA membrane in vivo. Following the evaluation criteria of the ISO 10993-6 standard, we demonstrated that the CGP/PVA membrane showed moderate tissue reaction, with a non-irritating ISO pattern, a thinner fibrous capsule, and a smaller amount of collagen compared to the positive control group. At 30 and 60 days, the membrane presented a similar amount of mast cells to that observed in the negative control group. The data demonstrate that the CGP/PVA membrane presents biocompatibility in accordance with the ISO 10993-6 standard.

30 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
JAJoilma Cruz da Silva Araújo
Joilma Cruz da Silva Araújo
JSJaqueline Correia Pontes Serra
Jaqueline Correia Pontes Serra
KAKelliane Martins de Araújo
Kelliane Martins de Araújo
MCMarcos de Oliveira Cunha
Marcos de Oliveira Cunha
LCLilian Carla Carneiro
Lilian Carla Carneiro
The study aimed to assess the prevalence of COVID-19 and Klebsiella spp. coinfection across continents. Conducted following PRISMA guidelines, a systematic review utilized PubMed, Embase, SCOPUS, ScienceDirect, and Web of Science databases, searching for literature in English published from December 2019 to December 2022, using specific Health Sciences descriptors. A total of 408 records were identified, but only 50 were eligible, and of these, only 33 were included. Thirty-three references were analyzed to evaluate the correlation between COVID-19 and Klebsiella spp. infections. The tabulated data represented a sample group of 8741 coinfected patients. The findings revealed notable disparities in co-infection rates across continents. In Asia, 23% of individuals were infected with Klebsiella pneumoniae, while in Europe, the proportion of co-infected patients stood at 15%. Strikingly, on the African continent, 43% were found to be infected with Klebsiella pneumoniae, highlighting significant regional variations. Overall, the proportion of Klebsiella pneumoniae co-infections among COVID-positive individuals were determined to be 19%. Particularly concerning was the observation that 1 in 6 ICU coinfections was attributed to Klebsiella pneumoniae, indicating its substantial impact on patient outcomes and healthcare burden. The study underscores the alarming prevalence of co-infection between COVID-19 and Klebsiella pneumoniae, potentially exacerbating the clinical severity of patients and posing challenges to treatment strategies. These findings emphasize the importance of vigilant surveillance and targeted interventions to mitigate the adverse effects of bacterial coinfections in the context of the COVID-19 pandemic.

18 July 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
WAWinnie Castro e Amorim Albuquerque
Winnie Castro e Amorim Albuquerque
RGRaylane Pereira Gomes
Raylane Pereira Gomes
RRRogério Elias Rabelo
Rogério Elias Rabelo
LSLuiz Antônio Franco da Silva
Luiz Antônio Franco da Silva
LCLilian Carla Carneiro
Lilian Carla Carneiro
Bovine papilomavírus (BPVs) is the etiological agent of bovine papillomatosis, a disease that triggers warts throughout the skin, udder, roofs, genitalia and in more severe cases can develop extensive papillomas, cause neoplasia in the digestive tract and bladder, cause losses in productivity and losses to livestock. In Brazil, the occurrence of BPV infection is relatively common, but the identification of viral types is still sporadic. The present study is a research report that aimed to describe the occurrence of BPV infections in dairy cattle affected by papillomatosis, based on the nucleotide sequences of the ORF L1, the most conserved sequence. Twenty-five samples of cutaneous wart from nine cattle clinically diagnosed as cutaneous papillomatosis were analyzed in the state of Goiás, central-western Brazil. Amplification was obtained in 11 samples (papilloma) from different cattle. PCR reactions followed by sequencing revealed the presence of BPV-1 in 60%, BPV-5 in 40%, and BPV-14 in 20% of the samples analyzed. The presence of coinfection was verified in 60% of the amplified samples. These data suggest that several types of BPV can infect a lesion simultaneously and demonstrate the possibility that BPV infection in epithelial tissue can occur without restriction to one or two viral types, demonstrating the region's genetic diversity. As far as we know, this is the first registry of typification of BPVs of the central-western region of Brazil. This analysis provides important information for bovine papillomavirus (BPV) research in Brazil.

2 February 2023 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
LOLeiny Paula de Oliveira
Leiny Paula de Oliveira
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
TSTainara Ribeiro de Souza
Tainara Ribeiro de Souza
IAIsabela Rodrigues Araújo
Isabela Rodrigues Araújo
LMLiliana Borges de Menezes
Liliana Borges de Menezes
VVValcinir Aloisio Scalla Vulcani
Valcinir Aloisio Scalla Vulcani

30 October 2023
Verified
Book Chapter
Open access
PDF file
ACAngelica de Lima das Chagas
Angelica de Lima das Chagas
Biocompatibility is the ability of biomaterials to promote and influence the tissue repair process, and to interact with tissues and organs without causing damage or compromising the biomaterial. The aim of this narrative review was to deepen the theoretical concept of the interaction between biomaterial and tissue. In addition to providing an accessible view of biocompatibility without ignoring the concepts. In this vein, the mechanisms of biocompatibility were analyzed, such as the systemic and local physiological response to biomaterials in order to improve clinical applicability. The interaction between biomaterials and the tissue interface is a complex chain of reactions between the organism and the device that can be modulated by the properties of the biomaterial. Understanding this interaction allows us to develop better applicability strategies with better clinical results. DOI:https://doi.org/10.56238/uniknowindevolp-141